James Hardie Industries plc (ADR) (JHX) Reaches $14.75 Formed H&S; Clough Capital Partners LP Lifted Its Intra Cellular Therapies (ITCI) Stake

September 8, 2017 - By Adrian Erickson

Clough Capital Partners LP increased Intra Cellular Therapies Inc (ITCI) stake by 103.46% reported in 2016Q4 SEC filing. Clough Capital Partners LP acquired 177,800 shares as Intra Cellular Therapies Inc (ITCI)’s stock declined 19.44%. The Clough Capital Partners LP holds 349,650 shares with $5.28M value, up from 171,850 last quarter. Intra Cellular Therapies Inc now has $949.17 million valuation. The stock increased 16.50% or $3.13 during the last trading session, reaching $22.1. About shares traded. ITI Inc (NASDAQ:ITCI) has declined 68.76% since September 8, 2016 and is downtrending. It has underperformed by 85.46% the S&P500.

James Hardie Industries plc (ADR) (JHX) formed H&S with $13.42 target or 9.00% below today’s $14.75 share price. James Hardie Industries plc (ADR) (JHX) has $6.48B valuation. The stock increased 1.72% or $0.25 on September 7, reaching $14.75. About shares traded. James Hardie Industries plc (ADR) (NYSE:JHX) has risen 5.20% since September 8, 2016 and is uptrending. It has underperformed by 11.50% the S&P500.

Among 10 analysts covering Intra-Cellular Therapies (NASDAQ:ITCI), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Intra-Cellular Therapies had 28 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Thursday, September 29 by SunTrust. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, August 9 report. The stock of ITI Inc (NASDAQ:ITCI) has “Buy” rating given on Tuesday, June 6 by Cowen & Co. JMP Securities maintained it with “Market Outperform” rating and $55 target in Wednesday, March 9 report. The stock of ITI Inc (NASDAQ:ITCI) earned “Overweight” rating by Piper Jaffray on Thursday, June 2. On Thursday, September 17 the stock rating was maintained by Guggenheim with “Buy”. The stock of ITI Inc (NASDAQ:ITCI) has “Market Perform” rating given on Thursday, September 29 by JMP Securities. The stock has “Hold” rating by Piper Jaffray on Wednesday, August 9. Leerink Swann upgraded the stock to “Buy” rating in Wednesday, August 23 report. The firm has “Market Outperform” rating by JMP Securities given on Thursday, August 24.

Clough Capital Partners LP decreased Charter Communications Inc N stake by 68,200 shares to 93,821 valued at $27.01M in 2016Q4. It also reduced Solar Cap Ltd (NASDAQ:SLRC) stake by 19,200 shares and now owns 737,431 shares. Ares Cap Corp (NASDAQ:ARCC) was reduced too.

Investors sentiment increased to 0.86 in 2016 Q4. Its up 0.02, from 0.84 in 2016Q3. It improved, as 25 investors sold ITCI shares while 23 reduced holdings. 27 funds opened positions while 43 raised stakes. 29.52 million shares or 8.32% more from 27.25 million shares in 2016Q3 were reported. Clough Cap Prns Limited Partnership owns 349,650 shares or 0.35% of their US portfolio. The Massachusetts-based Numeric Invsts Ltd Limited Liability Company has invested 0.01% in ITI Inc (NASDAQ:ITCI). Moreover, Susquehanna Gru Limited Liability Partnership has 0% invested in ITI Inc (NASDAQ:ITCI). Moreover, Blackrock Institutional Tru Co Na has 0% invested in ITI Inc (NASDAQ:ITCI) for 940,753 shares. Sei Investments reported 0.01% in ITI Inc (NASDAQ:ITCI). Rock Springs Cap Lp has invested 0.19% in ITI Inc (NASDAQ:ITCI). 18,320 were accumulated by Fiera Cap. New York-based Alpine Woods Cap Invsts Ltd Liability has invested 0.06% in ITI Inc (NASDAQ:ITCI). Stifel Fincl accumulated 14,100 shares or 0% of the stock. C M Bidwell & Associates Ltd has 16,175 shares. Metropolitan Life Insur New York accumulated 0% or 25,164 shares. Nj State Employees Deferred Compensation Plan holds 0.05% or 17,500 shares in its portfolio. Moreover, Rhumbline Advisers has 0% invested in ITI Inc (NASDAQ:ITCI) for 40,396 shares. Citigroup Incorporated reported 0% of its portfolio in ITI Inc (NASDAQ:ITCI). Millennium Mgmt Ltd Liability Co accumulated 486,493 shares.

Among 2 analysts covering James Hardie Industries plc. (NYSE:JHX), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. James Hardie Industries plc. had 2 analyst reports since August 15, 2016 according to SRatingsIntel. The firm has “Neutral” rating by Citigroup given on Monday, August 15. The rating was upgraded by CLSA on Friday, April 21 to “Outperform”.